Drug Approval | August 06, 2021
India’s gets its first bio-bank for heart failure research
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
He will be stationed at the company HQ in Bengaluru, India
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
The company has been consistently reducing debt
The data should be submitted by August 12th 2021
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Innovative solutions and a deep understanding of the market makes this a unique combination
It had an estimated market size of US $ 32 million as of June 2021
Subscribe To Our Newsletter & Stay Updated
